May 02, 2023 / 05:30PM GMT
Unidentified_1
I'd like to welcome everybody back to the H.C. Wainwright BioConnect conference, and we are continuing with our afternoon session here. Our next presenter is Adrian Gottschalk, President and CEO of Foghorn Therapeutics. Welcome.
Adrian Gottschalk - Foghorn Therapeutics Inc. - President & CEO
Great, Andres. Thanks. And you get extra points for pronouncing the last name correctly. So it's very rare that that ever happens. So just maybe credit that. Thanks for having me.
Questions and Answers:
Unidentified_1Of course. So I guess for investors who are not as familiar with the Foghorn story, could you give us a brief overview of the unique ways you're tackling various indications within oncology?
Adrian Gottschalk - Foghorn Therapeutics Inc. - President & CEO
Sure. So maybe I'll just take a step back and talk about what we're actually working on and then talk about the drug immodality and our strategy to get after some of the unique targets on which we're focused.
Trustpilot
